Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 May;58(5):383–387. doi: 10.1136/thorax.58.5.383

Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus

J B M van Woensel 1, W M C van Aalderen 1, W de Weerd 1, N Jansen 1, J P J van Gestel 1, D Markhorst 1, A J van Vught 1, A Bos 1, J Kimpen 1
PMCID: PMC1746666  PMID: 12728156

Abstract

Background: A study was undertaken to evaluate the efficacy of dexamethasone in patients mechanically ventilated for lower respiratory infection caused by respiratory syncytial virus (RSV-LRTI).

Methods: In a multicentre randomised controlled trial patients were randomised to receive either intravenous dexamethasone (0.15 mg/kg 6 hourly for 48 hours) or placebo. End points were the duration of mechanical ventilation, length of stay (LOS) in the pediatric intensive care unit (PICU) and in hospital, and the duration of supplemental oxygen administration.

Results: Thirty seven patients received dexamethasone and 45 received placebo. There was no significant difference in any of the end points between the two groups. In a post hoc analysis patients were stratified into those with mild gas exchange anomalies (PaO2/FiO2 >200 mm Hg and/or mean airway pressure ⩽ 10 cm H2O, bronchiolitis group) and those with severe gas exchange anomalies (PaO2/FiO2 ⩽200 mm Hg and mean airway pressure >10 cm H2O, pneumonia group). In the 39 patients with bronchiolitis the duration of mechanical ventilation was 4.3 days shorter in the dexamethasone group than in the placebo group (4.9 v 9.2 days, 95% CI -7.8 to -0.8, p=0.02) and the duration of supplemental oxygen was 3.6 days shorter (7.7 v 11.3 days, 95% CI -8.0 to -0.1, p=0.048). No differences in end points were found in the pneumonia group.

Conclusions: Dexamethasone had no beneficial effect in patients mechanically ventilated for RSV-LRTI but was found to have a beneficial effect in patients with bronchiolitis.

Full Text

The Full Text of this article is available as a PDF (120.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger I., Argaman Z., Schwartz S. B., Segal E., Kiderman A., Branski D., Kerem E. Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol. 1998 Sep;26(3):162–166. doi: 10.1002/(sici)1099-0496(199809)26:3<162::aid-ppul2>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  2. Bernard G. R., Artigas A., Brigham K. L., Carlet J., Falke K., Hudson L., Lamy M., Legall J. R., Morris A., Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
  3. Buckingham Steven C., Jafri Hasan S., Bush Andrew J., Carubelli Cecilia M., Sheeran Paul, Hardy R. Doug, Ottolini Martin G., Ramilo Octavio, DeVincenzo John P. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis. 2002 Apr 16;185(9):1222–1228. doi: 10.1086/340024. [DOI] [PubMed] [Google Scholar]
  4. Connolly J. H., Field C. M., Glasgow J. F., Slattery C. M., MacLynn D. M. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand. 1969 Mar;58(2):116–120. doi: 10.1111/j.1651-2227.1969.tb04693.x. [DOI] [PubMed] [Google Scholar]
  5. Dabbous I. A., Tkachyk J. S., Stamm S. J. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics. 1966 Mar;37(3):477–484. [PubMed] [Google Scholar]
  6. De Boeck K., Van der Aa N., Van Lierde S., Corbeel L., Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr. 1997 Dec;131(6):919–921. doi: 10.1016/s0022-3476(97)70044-1. [DOI] [PubMed] [Google Scholar]
  7. Everard M. L., Milner A. D. The respiratory syncitial virus and its role in acute bronchiolitis. Eur J Pediatr. 1992 Sep;151(9):638–651. doi: 10.1007/BF01957564. [DOI] [PubMed] [Google Scholar]
  8. Glezen P., Denny F. W. Epidemiology of acute lower respiratory disease in children. N Engl J Med. 1973 Mar 8;288(10):498–505. doi: 10.1056/NEJM197303082881005. [DOI] [PubMed] [Google Scholar]
  9. Goebel J., Estrada B., Quinonez J., Nagji N., Sanford D., Boerth R. C. Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis. Clin Pediatr (Phila) 2000 Apr;39(4):213–220. doi: 10.1177/000992280003900404. [DOI] [PubMed] [Google Scholar]
  10. Graham B. S., Bunton L. A., Rowland J., Wright P. F., Karzon D. T. Respiratory syncytial virus infection in anti-mu-treated mice. J Virol. 1991 Sep;65(9):4936–4942. doi: 10.1128/jvi.65.9.4936-4942.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hammer J., Numa A., Newth C. J. Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol. 1997 Mar;23(3):176–183. doi: 10.1002/(sici)1099-0496(199703)23:3<176::aid-ppul2>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. Hammer J., Numa A., Newth C. J. Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection. J Pediatr. 1995 Sep;127(3):485–490. doi: 10.1016/s0022-3476(95)70088-9. [DOI] [PubMed] [Google Scholar]
  13. Kaditis A. G., Wald E. R. Viral croup: current diagnosis and treatment. Pediatr Infect Dis J. 1998 Sep;17(9):827–834. doi: 10.1097/00006454-199809000-00018. [DOI] [PubMed] [Google Scholar]
  14. Klassen T. P., Sutcliffe T., Watters L. K., Wells G. A., Allen U. D., Li M. M. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr. 1997 Feb;130(2):191–196. doi: 10.1016/s0022-3476(97)70342-1. [DOI] [PubMed] [Google Scholar]
  15. Leer J. A., Jr, Green J. L., Heimlich E. M., Hyde J. S., Moffet H. L., Young G. A., Barron B. A. Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. Am J Dis Child. 1969 May;117(5):495–503. [PubMed] [Google Scholar]
  16. Newth C. J. Time course of severe respiratory syncytial virus infection in mechanically ventilated infants. Acta Paediatr. 2000 Aug;89(8):893–895. doi: 10.1080/080352500750043279. [DOI] [PubMed] [Google Scholar]
  17. Openshaw P. J. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol. 1995;17(2-3):187–201. doi: 10.1007/BF00196165. [DOI] [PubMed] [Google Scholar]
  18. Quagliarello V. J., Scheld W. M. Treatment of bacterial meningitis. N Engl J Med. 1997 Mar 6;336(10):708–716. doi: 10.1056/NEJM199703063361007. [DOI] [PubMed] [Google Scholar]
  19. Roosevelt G., Sheehan K., Grupp-Phelan J., Tanz R. R., Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet. 1996 Aug 3;348(9023):292–295. doi: 10.1016/s0140-6736(96)02285-4. [DOI] [PubMed] [Google Scholar]
  20. SUSSMAN S., GROSSMAN M., MAGOFFIN R., SCHIEBLE J. DEXAMETHASONE (16-ALPHA-METHYL, 9-ALPHA-FLUOROPREDNISOLONE) IN OBSTRUCTIVE RESPIRATORY TRACT INFECTIONS IN CHILDREN. A CONTROLLED STUDY. Pediatrics. 1964 Dec;34:851–855. [PubMed] [Google Scholar]
  21. Shay D. K., Holman R. C., Newman R. D., Liu L. L., Stout J. W., Anderson L. J. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999 Oct 20;282(15):1440–1446. doi: 10.1001/jama.282.15.1440. [DOI] [PubMed] [Google Scholar]
  22. Springer C., Bar-Yishay E., Uwayyed K., Avital A., Vilozni D., Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol. 1990;9(3):181–185. doi: 10.1002/ppul.1950090311. [DOI] [PubMed] [Google Scholar]
  23. Stretton M., Ajizian S. J., Mitchell I., Newth C. J. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol. 1992 Jul;13(3):143–150. doi: 10.1002/ppul.1950130304. [DOI] [PubMed] [Google Scholar]
  24. Tal A., Bavilski C., Yohai D., Bearman J. E., Gorodischer R., Moses S. W. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. 1983 Jan;71(1):13–18. [PubMed] [Google Scholar]
  25. Tasker R. C., Gordon I., Kiff K. Time course of severe respiratory syncytial virus infection in mechanically ventilated infants. Acta Paediatr. 2000 Aug;89(8):938–941. doi: 10.1080/080352500750043387. [DOI] [PubMed] [Google Scholar]
  26. van Woensel J. B., Wolfs T. F., van Aalderen W. M., Brand P. L., Kimpen J. L. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax. 1997 Jul;52(7):634–637. doi: 10.1136/thx.52.7.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. van Woensel J., Kimpen J. Therapy for respiratory tract infections caused by respiratory syncytial virus. Eur J Pediatr. 2000 Jun;159(6):391–398. doi: 10.1007/s004310051295. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES